2023. Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic. Brazilian Journal of Pharmaceutical Sciences. 59, (Apr. 2023), e21067. DOI:https://doi.org/10.1590/s2175-97902023e21067.